₹33.00
-0.03 (-0.09%)
As of 22 Sept 2026, Pentokey Organy (India) Ltd share price is ₹33.00. The stock opened at ₹33.00 and had closed at ₹33.03 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹28.49 and a high of ₹57.00. In terms of performance, Pentokey Organy (India) Ltd share price has decreased by 6.78% over the past six months and has decreased by 26.32% over the last year.
Pentokey Organy Stock Price Chart
Pentokey Organy (India) Ltd Overview
Market cap₹21 Crs
Volume1,775
Prev. Close₹33.03
Year range₹28.49 - ₹57.00
ISININE702E01015
About Pentokey Organy
Pentokey Organy (India) engaged in trading of Pharmaceutical Goods.
Pentokey Organy (India) Ltd Historical Performance
1 Month Return0.06%
6 Month Return-7.28%
3 Year Return-39.91%
3 Month Return-9.27%
1 Year Return-26.67%
5 Year Return53.85%
Pentokey Organy (India) Ltd Fundamentals
ROCE(TTM)2.56%
P/E Ratio (TTM)76.74
P/B Ratio2.13
Debt to Equity0.00
ROE2.53%
EPS (TTM)0.43
Dividend Yield0.00%
Book Value15.46
Profit Margin27.55%
Operating Margin-41.84%
Pentokey Organy (India) Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 1.29 | 1.29 | 4.85 | 6.73 | 0.25 |
| EBITDA | 0.25 | 0.25 | 0.88 | 3.21 | -0.16 |
| Net Profit | 0.25 | 0.25 | 0.87 | 3.18 | -0.16 |
| EPS | 0.39 | 0.39 | 1.39 | 5.06 | -0.26 |
Pentokey Organy (India) Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 30.69 |
| Resistance 1 (R1) | 34.69 |
| Pivot Point | 32.34 |
Pentokey Organy (India) Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Purusottam Kejriwal | Non Executive Independent Director |
| Prajakta Shidhore | Non Executive Independent Director |
| Arun Kumar Goenka | Non Executive Independent Director |
Pentokey Organy (India) Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Pentokey Organy (India) Ltd today is ₹33.00 on NSE and ₹33.00 on BSE.
- The 52-week high of Pentokey Organy (India) Ltd is ₹57.00, while the 52-week low is ₹28.49.
- The current market capitalisation of Pentokey Organy (India) Ltd is approximately ₹21 crore.
- The P/E (Price-to-Earnings) ratio of Pentokey Organy (India) Ltd is 76.74. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Pentokey Organy (India) Ltd is 2.13. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Pentokey Organy (India) Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Pentokey Organy on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Pentokey Organy (India) Ltd has delivered a return of approximately -39.91%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Pentokey Organy (India) Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 73.03% promoters, 0.00% FIIs, 2.31% DIIs, and 16.27% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
